Article
High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversion
2021-02-23
Abstract excerpt
Biomarkers for COVID-19 are urgently needed. Here we bring the powerful technology of mass spectrometry (MS)-based proteomics to bear on this challenge. We measured serum proteomes of COVID-19 patients and symptomatic, but PCR-negative controls, in a time-resolved manner. In 262 controls and 458 longitudinal samples (average of 31 days) of 31 patients, hospitalized for COVID-19, a remarkable 26% of proteins change...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 931a048c-f062-5a98-8fcf-dc6ea5cbc276
- DOI
- 10.1101/2021.02.22.21252236
